Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Sign in
Join now
Eric Kallwitz MD

Eric R. Kallwitz MD

Associate Professor of Medicine, Section of Hepatology, Loyola University Medical Center, Maywood, Illinois

Biographical Sketch:

Dr. Eric Kallwitz is Associate Professor of Medicine in the Division of Hepatology at Loyola University Stritch School of Medicine in Maywood, Illinois. He is a practicing gastroenterologist at the Loyola University Medical Center, specializing in hepatology, transplant hepatology, fatty liver disease, endoscopy, and viral hepatitis.

Dr. Kallwitz received his medical degree from Rush Medical College in Chicago, and his residency training in internal medicine at the University of Chicago. He completed fellowships in gastroenterology and hepatology and transplant hepatology at the University of Illinois at Chicago.

Positions:

Assistant Professor of Medicine, Division of Hepatology, Loyola University Stritch School of Medicine, Loyola University Medical Center, Maywood, Illinois

Degrees:

MD: Rush Medical College, Chicago, Illinois

Postgraduate Training:

Fellowship (gastroenterology and hepatology): University of Illinois at Chicago, Chicago, Illinois

Fellowship (transplant hepatology): University of Illinois at Chicago, Chicago, Illinois

Clinical Interests:

Transplant hepatology, general hepatology, fatty liver disease, endoscopy, viral hepatitis

Disclosures

Dr. Kallwitz has no relevant disclosures.

Recent Contributions to PracticeUpdate:

  1. Association Between Hepatic Steatosis and Incident Cardiovascular Disease, Cancer, and All-Cause Mortality
  2. Association of Myosteatosis With Fibrosis Progression and Early Steatohepatitis in Patients With NAFLD
  3. PNPLA3 Polymorphism Decreases Incident Diabetes Risk in Patients With NAFLD
  4. The Beneficial Effects of the Mediterranean Diet Over a Low-Fat Diet May Be Mediated by Decreasing Hepatic Fat Content
  5. Gastroenterology PracticeChanger in 2015: Rethinking Assessment and Treatment of Non-Alcoholic Fatty Liver Disease (NAFLD)
  6. Nonalcoholic Fatty Liver Disease: Not Easy to Diagnose or Treat
  7. Nonalcoholic Fatty Liver Disease
  8. Weight Loss Through Lifestyle Modification Significantly Reduces NASH
  9. How Much Is Enough Exercise in Non-Alcoholic Fatty Liver Disease?
  10. Weight Loss Reduces Features of Nonalcoholic Steatohepatitis

Most Read This Week

Recently Updated